JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.85B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.5B |
| 3 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.21B |
| 4 |
Chevron
CVX
|
+$1.08B |
| 5 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$986M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.61B |
| 2 |
Occidental Petroleum
OXY
|
+$1.36B |
| 3 |
Merck
MRK
|
+$913M |
| 4 |
Visa
V
|
+$801M |
| 5 |
AT&T
T
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.95% |
| 2 | Technology | 12.9% |
| 3 | Financials | 12.36% |
| 4 | Healthcare | 9.31% |
| 5 | Consumer Discretionary | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4451
BCB Bancorp
BCBP
$260M
| $214K | ﹤0.01% |
16,989
+7,413
| +77% | +$95.1K |
2017 Q4
6 quarters
|
|
|
ECOM
4452
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $214K | ﹤0.01% |
24,156
+10,482
| +77% | +$109K |
2016 Q3
11 quarters
|
|
|
CCF
4453
DELISTED
Chase Corporation
CCF
| $213K | ﹤0.01% |
2,010
-9,430
| -82% | -$934K |
2017 Q4
6 quarters
|
|
4454
First Trust Energy AlphaDEX Fund
FXN
$372M
| $211K | ﹤0.01% |
+18,705
| New | +$226K |
2019 Q2
0 quarters
|
|
4455
CALL
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$25.8B
| $210K | ﹤0.01% |
+600
| New | +$210K |
2019 Q2
0 quarters
|
|
|
4456
PUT
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$25.8B
| $210K | ﹤0.01% |
+600
| New | +$210K |
2019 Q2
0 quarters
|
|
4457
CorVel
CRVL
$3.84B
| $209K | ﹤0.01% |
7,431
+900
| +14% | +$22.2K |
2015 Q4
14 quarters
|
|
4458
iShares Currency Hedged MSCI Japan ETF
HEWJ
$668M
| $209K | ﹤0.01% |
6,912
+81
| +1% | +$2.47K |
2015 Q1
17 quarters
|
|
|
SRGA
4459
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $209K | ﹤0.01% |
1,574
+1,051
| +201% | +$151K |
2017 Q4
6 quarters
|
|
4460
iShares US Industrials ETF
IYJ
$2.02B
| $208K | ﹤0.01% |
2,656
-682
| -20% | -$52.7K |
2015 Q4
14 quarters
|
|
|
NAGE
4461
Niagen Bioscience
NAGE
$212M
| $208K | ﹤0.01% |
44,807
+35,418
| +377% | +$151K |
2018 Q2
4 quarters
|
|
4462
State Street SPDR Bloomberg International Corporate Bond ETF
IBND
$438M
| $207K | ﹤0.01% |
6,052
-53,519
| -90% | -$1.79M |
2013 Q2
24 quarters
|
|
4463
Icahn Enterprises
IEP
$4.74B
| $207K | ﹤0.01% |
2,849
-470
| -14% | -$34.1K |
2015 Q1
17 quarters
|
|
4464
Amphastar Pharmaceuticals
AMPH
$1.08B
| $205K | ﹤0.01% |
9,856
+1,314
| +15% | +$27.5K |
2014 Q3
19 quarters
|
|
4465
Manitowoc
MTW
$848M
| $205K | ﹤0.01% |
11,666
+1,648
| +16% | +$27.3K |
2015 Q3
15 quarters
|
|
4466
Century Casinos
CNTY
$29M
| $203K | ﹤0.01% |
20,897
+14,303
| +217% | +$131K |
2017 Q4
6 quarters
|
|
4467
Prospect Capital
PSEC
$1.03B
| $203K | ﹤0.01% |
31,548
-816
| -3% | -$5.4K |
2015 Q2
16 quarters
|
|
|
SOHO
4468
DELISTED
Sotherly Hotels
SOHO
| $203K | ﹤0.01% |
29,675
+2,700
| +10% | +$19K |
2016 Q4
10 quarters
|
|
4469
Banc of California
BANC
$2.78B
| $202K | ﹤0.01% |
14,720
+1,786
| +14% | +$25.2K |
2017 Q2
8 quarters
|
|
4470
ProShares MSCI Europe Dividend Growers ETF
EUDV
$7.96M
| $202K | ﹤0.01% |
+5,000
| New | +$201K |
2019 Q2
0 quarters
|
|
4471
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
$15.3B
| $202K | ﹤0.01% |
3,465
-557
| -14% | -$32.2K |
2017 Q4
6 quarters
|
|
4472
ProShares UltraShort S&P500
SDS
$360M
| $202K | ﹤0.01% |
260
-69
| -21% | -$55.5K |
2018 Q2
4 quarters
|
|
4473
iShares 10-20 Year Treasury Bond ETF
TLH
$10.7B
| $202K | ﹤0.01% |
+1,411
| New | +$195K |
2019 Q2
0 quarters
|
|
|
TELL
4474
DELISTED
Tellurian Inc.
TELL
| $202K | ﹤0.01% |
25,938
-198,447
| -88% | -$1.76M |
2017 Q4
6 quarters
|
|
|
ALLK
4475
DELISTED
Allakos
ALLK
| $201K | ﹤0.01% |
4,765
+1,314
| +38% | +$53.9K |
2018 Q3
3 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2019 Portfolio in Review
As of Q2 2019, JP Morgan Chase held 6,226 positions worth $511B, up 4.5% from $490B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q2 2019 filing shows 458 new, 2,668 increased, 2,116 reduced and 420 closed positions. Its largest new stake was Corteva: 13,119,143 shares worth $388M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $3.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, up from 27% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2019 buy was Corteva: 13,119,143 shares worth $388M.
- JP Morgan Chase added most to iShares 0-1 Year Treasury Bond ETF in Q2 2019, an estimated $3.85B increase.
- JP Morgan Chase's biggest Q2 2019 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.61B.
- JP Morgan Chase fully exited Goldcorp Inc in Q2 2019, selling an estimated $131M.
- JP Morgan Chase's ten largest holdings make up 16% of its $511B portfolio in Q2 2019.
- JP Morgan Chase opened 458 new positions and closed 420 in Q2 2019.
- JP Morgan Chase's portfolio value rose 4.5% quarter-over-quarter to $511B.
Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.